Symbol="ALDX"
AssetType="Common Stock"
Name="Aldeyra The"
Description="Aldeyra Therapeutics, Inc., a biotechnology company, develops and markets drugs for immune-mediated systemic and eye diseases. The company is headquartered in Lexington, Massachusetts."
CIK="1341235"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="466854000"
EBITDA="-62736620"
PERatio="None"
PEGRatio="0"
BookValue="2.334"
DividendPerShare="0"
DividendYield="0"
EPS="-1.02"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.202"
ReturnOnEquityTTM="-0.371"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.02"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.239"
EVToRevenue="-"
EVToEBITDA="-3.075"
Beta="1.078"
num_52WeekHigh="11.97"
num_52WeekLow="4.954"
num_50DayMovingAverage="8.92"
num_200DayMovingAverage="7.66"
SharesOutstanding="58576000"
DividendDate="None"
ExDividendDate="None"
symbol="ALDX"
open="7.89"
high="8.05"
low="7.80"
price="7.97"
volume="491257.00"
latest_trading_day="2023-08-02"
previous_close="8.00"
change="-0.03"
change_percent="-0.3750%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="30"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="1156902"
Change_recent_avg="0.03"
Delta_recent_avg="0.53"
Variance_recent_avg="0.26"
Change_ratio_recent_avg="0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="548"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_positive_thumbnail_id_1="986"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
